iRhythm Holdings, Inc.
$124.91
▼
-1.2%
2026-04-21 07:35:01
www.irhythmtech.com
NMS: IRTC
Explore iRhythm Holdings, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.04 B
Current Price
$124.91
52W High / Low
$212 / $97.16
Stock P/E
—
Book Value
$4.73
Dividend Yield
—
ROCE
-5.75%
ROE
-36.57%
Face Value
—
EPS
$-1.39
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
2,400
Beta
1.18
Debt / Equity
478.69
Current Ratio
4.63
Quick Ratio
4.48
Forward P/E
137.79
Price / Sales
4.98
Enterprise Value
$3.87 B
EV / EBITDA
-126.66
EV / Revenue
5.18
Rating
Strong Buy
Target Price
$201.71
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Insulet Corporation | $193.4 | 55.6 | $13.48 B | — | 18.87% | 18.12% | $354.88 / $194.61 | $21.53 |
| 2. | Bruker Corporation | $41.1 | — | $6.23 B | 0.49% | 4.76% | -0.38% | $56.22 / $28.53 | $16.15 |
| 3. | Modular Medical, Inc. | $5.41 | — | $27.31 M | — | -109.03% | -3.32% | $34.5 / $3.55 | $2.27 |
| 4. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
| 5. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 6. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
| 7. | Phaos Technology Holdings (Caym | $1.95 | — | — | — | 214.51% | -10.73% | $7.39 / $0.53 | $-0.06 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 208.89 M | 192.88 M | 186.69 M | 158.68 M | 164.32 M | — |
| Operating Profit | 5 M | -8.13 M | -16.23 M | -32.56 M | -4.08 M | — |
| Net Profit | 5.58 M | -5.21 M | -14.22 M | -30.7 M | -1.33 M | — |
| EPS in Rs | 0.17 | -0.16 | -0.44 | -0.95 | -0.04 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 747.14 M | 591.84 M | 492.68 M | 410.92 M |
| Operating Profit | -49.91 M | -114.86 M | -114.08 M | -87.18 M |
| Net Profit | -44.55 M | -113.29 M | -123.41 M | -116.16 M |
| EPS in Rs | -1.38 | -3.51 | -3.82 | -3.59 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.02 B | 931.45 M | 433.14 M | 448.22 M |
| Total Liabilities | 867.3 M | 840.54 M | 223.05 M | 208.41 M |
| Equity | 152.75 M | 90.91 M | 210.1 M | 239.81 M |
| Current Assets | 702.76 M | 645.82 M | 230.81 M | 288.77 M |
| Current Liabilities | 151.89 M | 110.92 M | 107.37 M | 89.1 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 80.86 M | 3.39 M | -50.1 M | -23.01 M |
| Investing CF | -277.06 M | -122.98 M | -1.21 M | -52.43 M |
| Financing CF | 12.61 M | 511.38 M | 8.82 M | 26.72 M |
| Free CF | 34.52 M | -45.55 M | -90.53 M | -52.84 M |
| Capex | -46.34 M | -48.94 M | -40.42 M | -29.83 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 20.13% | 19.9% | — | — |
| Earnings Growth % | 8.2% | -6.24% | — | — |
| Profit Margin % | -19.14% | -25.05% | -28.27% | — |
| Operating Margin % | -19.41% | -23.16% | -21.21% | — |
| Gross Margin % | 68.86% | 67.35% | 68.54% | — |
| EBITDA Margin % | -12.52% | -19.66% | -22.42% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.